Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 25, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07840599). This is a study registration, not published results. Lead sponsor: Northwestern University. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 224 participants (ESTIMATED). Conditions: Metastatic Breast Cancer, Metastatic Breast Cancer (MBC), Metastatic Breastcancer. Interventions: BEHAVIORAL: Core Intervention; BEHAVIORAL: EHR Integration (On v. Off); BEHAVIORAL: Weekly Coaching; BEHAVIORAL: Social+ (on v. off); BEHAVIORAL: Static Goal Setting; BEHAVIORAL: Bi-Weekly Coaching; BEHAVIORAL: Highly Tailored Goal Setting. Primary outcome measures: Change in Steps , Baseline, 12 and 24 weeks. Brief summary: The purpose of this study is to examine which of four components of a digital health intervention using an App and Fitbit meaningfully contribute to increased physical activity in Metastatic Breast Cancer Patients. Participants will be asked to: * Wear a Fitbit and use an app, use 0 to 3 other components for 24 weeks and attend 6 or 12 coaching coaching calls in the first 12 weeks to increase daily steps. * Complete a questionnaire at baseline, week 12 and week 24 * Complete functional performance test (FPT) via Zoom at baseline, week 12 and week 24 * Wear a research activity monitor (Accelerometer) for 7 days at baseline, week 12 and week 24